![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 32, 28572-28577, August 9, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
From the Mutations in Parkin (a ubiquitin protein ligase)
are involved in autosomal recessive juvenile parkinsonism, but it is
not known how they cause nigral cell death. We examined the effect of
Parkin overexpression on cellular levels of oxidative damage, antioxidant defenses, nitric oxide production, and proteasomal enzyme
activity. Increasing expression of Parkin by gene transfection in NT-2
and SK-N-MC cells led to increased proteasomal activity, decreased
levels of protein carbonyls, 3-nitrotyrosine-containing proteins, and a
trend to a reduction in ubiquitinated protein levels. Transfection of
these cells with DNA encoding three mutant Parkins associated with
autosomal recessive juvenile parkinsonism (Del 3-5, T240R, and
Q311X) gave smaller increases in proteasomal activity and
led to elevated levels of protein carbonyls and lipid peroxidation.
Turnover of the mutant proteins was slower than that of the wild-type
protein, and both could be blocked by the proteasome inhibitor,
lactacystin. A rise in levels of nitrated proteins and increased levels
of NO
Wolfson Centre for Age-related
Diseases, GKT School of Biomedical Sciences, King's College London,
London SE1 1UL, United Kingdom, the § Department of
Neurology, Juntendo University School of Medicine, Tokyo, Japan
113-8421, and the ¶ Department of Biochemistry, National
University of Singapore, Kent Ridge Crescent,
Singapore 119260, Singapore


To whom correspondence should be addressed: Wolfson Centre for
Age-related Diseases, GKT School of Biomedical Sciences, King's College, London SE1 1UL, UK. Tel.: 44-20-7848-6011; Fax:
44-20-7848-6034; E-mail: div.pharm@kcl.ac.uk.
This article has been cited by other articles:
![]() |
M. Stefani Generic Cell Dysfunction in Neurodegenerative Disorders: Role of Surfaces in Early Protein Misfolding, Aggregation, and Aggregate Cytotoxicity Neuroscientist, October 1, 2007; 13(5): 519 - 531. [Abstract] [PDF] |
||||
![]() |
D. Versari, J. Herrmann, M. Gossl, D. Mannheim, K. Sattler, F. B. Meyer, L. O. Lerman, and A. Lerman Dysregulation of the Ubiquitin-Proteasome System in Human Carotid Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2132 - 2139. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yang, S. Gehrke, Y. Imai, Z. Huang, Y. Ouyang, J.-W. Wang, L. Yang, M. F. Beal, H. Vogel, and B. Lu Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin PNAS, July 11, 2006; 103(28): 10793 - 10798. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Smith, H. Jiang, Z. Pei, Y. Tanaka, H. Morita, A. Sawa, V. L. Dawson, T. M. Dawson, and C. A. Ross Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity Hum. Mol. Genet., December 15, 2005; 14(24): 3801 - 3811. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Springer, T. Hoppe, E. Schmidt, and R. Baumeister A Caenorhabditis elegans Parkin mutant with altered solubility couples {alpha}-synuclein aggregation to proteotoxic stress Hum. Mol. Genet., November 15, 2005; 14(22): 3407 - 3423. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cecchi, S. Baglioni, C. Fiorillo, A. Pensalfini, G. Liguri, D. Nosi, S. Rigacci, M. Bucciantini, and M. Stefani Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates J. Cell Sci., August 1, 2005; 118(15): 3459 - 3470. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Whitworth, D. A. Theodore, J. C. Greene, H. Benes, P. D. Wes, and L. J. Pallanck Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease PNAS, May 31, 2005; 102(22): 8024 - 8029. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.C. Williams, L.S. Cartwright, and D.B. Ramsden Parkinson's disease: the first common neurological disease due to auto-intoxication? QJM, March 1, 2005; 98(3): 215 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamamoto, A. Friedlein, Y. Imai, R. Takahashi, P. J. Kahle, and C. Haass Parkin Phosphorylation and Modulation of Its E3 Ubiquitin Ligase Activity J. Biol. Chem., February 4, 2005; 280(5): 3390 - 3399. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang, Y. Ren, J. Zhao, and J. Feng Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis Hum. Mol. Genet., August 15, 2004; 13(16): 1745 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bucciantini, G. Calloni, F. Chiti, L. Formigli, D. Nosi, C. M. Dobson, and M. Stefani Prefibrillar Amyloid Protein Aggregates Share Common Features of Cytotoxicity J. Biol. Chem., July 23, 2004; 279(30): 31374 - 31382. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pesah, T. Pham, H. Burgess, B. Middlebrooks, P. Verstreken, Y. Zhou, M. Harding, H. Bellen, and G. Mardon Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress Development, May 1, 2004; 131(9): 2183 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Palacino, D. Sagi, M. S. Goldberg, S. Krauss, C. Motz, M. Wacker, J. Klose, and J. Shen Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice J. Biol. Chem., April 30, 2004; 279(18): 18614 - 18622. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hedrich, A. Djarmati, N. Schafer, R. Hering, C. Wellenbrock, P. H. Weiss, R. Hilker, P. Vieregge, L. J. Ozelius, P. Heutink, et al. DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease Neurology, February 10, 2004; 62(3): 389 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Pawlyk, B. I. Giasson, D. M. Sampathu, F. A. Perez, K. L. Lim, V. L. Dawson, T. M. Dawson, R. D. Palmiter, J. Q. Trojanowski, and V. M.-Y. Lee Novel Monoclonal Antibodies Demonstrate Biochemical Variation of Brain Parkin with Age J. Biol. Chem., November 28, 2003; 278(48): 48120 - 48128. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Itier, P. Ibanez, M. A. Mena, N. Abbas, C. Cohen-Salmon, G. A. Bohme, M. Laville, J. Pratt, O. Corti, L. Pradier, et al. Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse Hum. Mol. Genet., September 15, 2003; 12(18): 2277 - 2291. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Tao and L. Tong Crystal Structure of Human DJ-1, a Protein Associated with Early Onset Parkinson's Disease J. Biol. Chem., August 15, 2003; 278(33): 31372 - 31379. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Corti, C. Hampe, H. Koutnikova, F. Darios, S. Jacquier, A. Prigent, J.-C. Robinson, L. Pradier, M. Ruberg, M. Mirande, et al. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration Hum. Mol. Genet., June 15, 2003; 12(12): 1427 - 1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bonifati, P. Rizzu, M. J. van Baren, O. Schaap, G. J. Breedveld, E. Krieger, M. C. J. Dekker, F. Squitieri, P. Ibanez, M. Joosse, et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism Science, January 10, 2003; 299(5604): 256 - 259. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |